Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pertuzumab 420 / Trastuzumab 6 / Docetaxel 75, Breast Cancer, adjuvant, cycle 2-4

Protocol-ID: 1166 V1.1 (Mini), PERT420/TRAS6/DOCE75, Breast Ca, adj., C2-4

Indication(s)

  • Breast Cancer (HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 09.10.2024